pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-499a |
Genomic Coordinates | chr20: 34990376 - 34990497 |
Description | Homo sapiens miR-499a stem-loop |
Comment | The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-499a-3p | ||||||||||||||||||||||||||||||
Sequence | 70| AACAUCACAGCAAGUCUGUGCU |91 | ||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||
Experiments | Cloned | DRVs in miRNA |
|
||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TRIM59 | ||||||||||||||||||||
Synonyms | IFT80L, MRF1, RNF104, TRIM57, TSBF1 | ||||||||||||||||||||
Description | tripartite motif containing 59 | ||||||||||||||||||||
Transcript | NM_173084 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TRIM59 | |||||||||||||||||||||
3'UTR of TRIM59 (miRNA target sites are highlighted) |
>TRIM59|NM_173084|3'UTR 1 AAATGTCAACCTGAATTGTTTAAATGGGCTTATTCTGTACATTGCTAAACAAAAAATGGGGTAGCATGGATAAAGAGCAA 81 ACTAAGCTTTATTAGTGCTGCAACTAATATAAACAAATGTTTATATTTGTTGCTTCTTTTGGTTAGCAATGATATGTCAA 161 AGTTATATCTGAAATAGTCAAATCTTTGGGAAACAGAATCTAGTAACAATTTGAAAAGTAATACACTATCCCATTTTTAT 241 TGGCTTTATGATGGTTGACATAATGTTGCTGTGACATTTAAACATTCTTGTACCAATATTGTCTTTTACCATTATTATAT 321 ACTGCAGTTAATTGGCTTTACAGTTCTTTATATATATAGCAAAATCCTGAAAGAACATATACCTTTATTTTGATGTGGCT 401 TGAAGCTTTTGAATGGGTGAATAAGGATGATAGAAAGGTTTCAAAATCAAGCAACAAAGTCTTAAAGTGATAAGGCATGG 481 CTTAAAGATCTTTTGATCAAACATACCTGTGTTTGAGATAGATTTAAGAGCCCTAAATGCTTATCACCATTCACTCCAAA 561 TAAAACTATTGCTTTTGGATAACTGTTAGAGTAAAGTGGCTTTTTAAAAGAAATTTTTGAGACTGGGTCTCACCTTGTTG 641 CCCAGGCTGGAGTGTAGTTGTCTGGTCATGACTCACTGCAGTTTCGACCACCCAGGCTCAATCGATCCTCCCGCCTCTGC 721 CTCTGGAGCAGCTGGGACAAGGCACACACCCCCATGCCTGGCTAATTAAAAAAATTGTTTTTTGTAGAAACGAGGTTTTG 801 CCATATTGCCCAGGTTGGTCTCAAACTTCTGGGCTCAAGAGATCTGCCCACCTTGGCCTCCCAAAGTGCTGGGATTACAG 881 ACGTTAGCCACACTGTGCCTGGGGGCCAGCATTTTCTAATACTTGTCATATTCTATAGTTTGTGCAAATTTAAGATTGTT 961 TTTTTTTCTGCTCGTCAGTCAAATCAGTTCTTGGATTAAAAACTCATTCTTATTAGAACAGAATCATGTTGGTAACTTGG 1041 TCTGCAACAGGTTTTGATGGCATCATGTGGACTTTATTCATCTTAACTCATTTAAATTTTCTACCACATTCCCTTAAGCT 1121 AATGCAAAAGTACCAACAACTTAATCTTTTTTTTTTTTTTTTTTTTTTTTTTTTGAGACGGAGTCTTGCTCTGTCGCCCA 1201 GGCTGGAGTGCAGTGGCGTGATCTCGGCTCATTGCAAGCCCCGCCTCCCGGGTTCACACCATTCTCCTGCCTCAGCCTCC 1281 CGAGTAGCTGGGACTACAGGCATCTGCTACCACGCCCAGCTAATTTTCTGTATTTTTAGTAGAGATGGGGTTTCACTGTG 1361 TTAGCCAGGATGGTCTCTATCTCCTGACCTCATGATCCACTCGCCTCAGCCTCCCAAAATGCTGGGATTATAGGCGTGAG 1441 CCGCCACGCCCGGCCCAACAACTTAATCTTTTATTAGCTTTGCTTAAGAGGGCCAATTAAATCAAAGCCCTTTAGTTCCC 1521 TTTAACAGGGACTGGAGTTATGATGCATGTGTTACGACTTTTGGCCCACTGTCCATGCAACTCTAAGTGCAGGTTGATTT 1601 GCTTTCCAGAAATCCCAAAGGGGCTGCTCTTGGATCACCGAAGAGCCTTACCTATATCAAATCAAAAAGACATTCTGGGT 1681 CAGATTAGACTATGCTCCTGGCCCTACAGATTGCACATAAACTATCATAAATACAGCTTTTTCAGGGAACTAGTTCTAAA 1761 ACTCTTACCTGCTGAGAATAAGTCTTAACACTAAGATGACTGTATTATATCAATTTATTATTAGAATCAGACTTATACCT 1841 AGCACAATTAACTATTGTGTGGGCAAAGAACATTTAAAGGGCATAGTAGAGGTAAGGAGAGACACATACTCAGCTAGAGA 1921 TAAAAATACTAAGTTGCACTGATTACTTAAAATACTAGTCACACCATAAAAGTGCCCTGTAGTTTCAAAAACACGTAAGC 2001 AATGAAATGTTAGCCATTATGTGTTAAACTACTTAATCTCATTTCTGTGATGTGAATATTTTTAACCCCCTTTTTGTAGA 2081 TGAGGGAACTGACAAGTGACTTGTCCAAGGCCATATAGCTGTGAGAAAACCCATGCATTCTCTTTTCAGAGTTCATGCTA 2161 TCACTCAACTTTAAAGTAGGCCAAGATTAATGTTGGTAAGGGTTTGTAATCTGTAAGAATGCTAAAAACGTAAGTATATA 2241 TATCATTTTAGATTTGACATTTTGTATCTTGCCAGTTTTTAGGAGAACTTTTCATTTTGTTAAGTATGCATGAATATAGT 2321 TGAGTATATGAGTAACTGGTTCTTATGCTGCTGTTTTGTATTTTTACCAGCAGGAAGATTGCAAAAGTTGATGTATGTAA 2401 ATCTTGAAATATTTCTAAGTTTTATGTATAACAAAATATGTATTTTAATAAACTTCTTTTGATATTTTAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 286827.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
CLIP-seq Support 1 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000309784.4 | 3UTR | UUAAACUACUUAAUCUCAUUUCUGUGAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
59 hsa-miR-499a-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT130131 | TXNIP | thioredoxin interacting protein | 2 | 2 | ||||||||
MIRT133678 | ETNK1 | ethanolamine kinase 1 | 2 | 2 | ||||||||
MIRT252103 | NAPG | NSF attachment protein gamma | 2 | 2 | ||||||||
MIRT260160 | IGFBP4 | insulin like growth factor binding protein 4 | 2 | 2 | ||||||||
MIRT388009 | DR1 | down-regulator of transcription 1 | 2 | 2 | ||||||||
MIRT441692 | ABLIM1 | actin binding LIM protein 1 | 2 | 6 | ||||||||
MIRT447799 | EPC2 | enhancer of polycomb homolog 2 | 2 | 2 | ||||||||
MIRT450657 | STYX | serine/threonine/tyrosine interacting protein | 2 | 4 | ||||||||
MIRT456843 | ZNF460 | zinc finger protein 460 | 2 | 2 | ||||||||
MIRT464134 | VPS35 | VPS35, retromer complex component | 2 | 2 | ||||||||
MIRT465101 | TSC22D3 | TSC22 domain family member 3 | 2 | 4 | ||||||||
MIRT470051 | PTGFRN | prostaglandin F2 receptor inhibitor | 2 | 2 | ||||||||
MIRT474146 | LIMA1 | LIM domain and actin binding 1 | 2 | 6 | ||||||||
MIRT474153 | LIFR | LIF receptor alpha | 2 | 2 | ||||||||
MIRT485327 | MYO1D | myosin ID | 2 | 2 | ||||||||
MIRT496403 | ZSCAN16 | zinc finger and SCAN domain containing 16 | 2 | 2 | ||||||||
MIRT497280 | MAF | MAF bZIP transcription factor | 2 | 2 | ||||||||
MIRT500970 | SPTSSA | serine palmitoyltransferase small subunit A | 2 | 2 | ||||||||
MIRT501536 | POM121C | POM121 transmembrane nucleoporin C | 2 | 6 | ||||||||
MIRT505174 | WDR76 | WD repeat domain 76 | 2 | 4 | ||||||||
MIRT505203 | UQCRB | ubiquinol-cytochrome c reductase binding protein | 2 | 4 | ||||||||
MIRT506745 | LIN54 | lin-54 DREAM MuvB core complex component | 2 | 4 | ||||||||
MIRT506799 | KLHL15 | kelch like family member 15 | 2 | 6 | ||||||||
MIRT525718 | DCAF12L2 | DDB1 and CUL4 associated factor 12 like 2 | 2 | 2 | ||||||||
MIRT530014 | SRRM1 | serine and arginine repetitive matrix 1 | 2 | 2 | ||||||||
MIRT531457 | PROSER2 | proline and serine rich 2 | 2 | 2 | ||||||||
MIRT532272 | CD93 | CD93 molecule | 2 | 2 | ||||||||
MIRT538715 | CAPRIN2 | caprin family member 2 | 2 | 4 | ||||||||
MIRT547356 | NAT8L | N-acetyltransferase 8 like | 2 | 2 | ||||||||
MIRT551468 | TRIM59 | tripartite motif containing 59 | 2 | 2 | ||||||||
MIRT555444 | NT5C3A | 5'-nucleotidase, cytosolic IIIA | 2 | 2 | ||||||||
MIRT555674 | PGAM4 | phosphoglycerate mutase family member 4 | 2 | 4 | ||||||||
MIRT557816 | FOXO1 | forkhead box O1 | 2 | 2 | ||||||||
MIRT557853 | FIGN | fidgetin, microtubule severing factor | 2 | 2 | ||||||||
MIRT557880 | FEM1B | fem-1 homolog B | 2 | 4 | ||||||||
MIRT562299 | GLO1 | glyoxalase I | 2 | 2 | ||||||||
MIRT563245 | QRFPR | pyroglutamylated RFamide peptide receptor | 2 | 2 | ||||||||
MIRT565571 | SLC7A2 | solute carrier family 7 member 2 | 2 | 2 | ||||||||
MIRT566214 | PTMA | prothymosin, alpha | 2 | 2 | ||||||||
MIRT575544 | Map4 | microtubule-associated protein 4 | 2 | 2 | ||||||||
MIRT609316 | FXYD6 | FXYD domain containing ion transport regulator 6 | 2 | 2 | ||||||||
MIRT609362 | ACOT2 | acyl-CoA thioesterase 2 | 2 | 2 | ||||||||
MIRT611163 | BTLA | B and T lymphocyte associated | 2 | 4 | ||||||||
MIRT611749 | CACNA1B | calcium voltage-gated channel subunit alpha1 B | 2 | 2 | ||||||||
MIRT615019 | ELK4 | ELK4, ETS transcription factor | 2 | 2 | ||||||||
MIRT623317 | MAPK1 | mitogen-activated protein kinase 1 | 2 | 2 | ||||||||
MIRT624550 | BMPR1A | bone morphogenetic protein receptor type 1A | 2 | 2 | ||||||||
MIRT633934 | DNAH9 | dynein axonemal heavy chain 9 | 2 | 2 | ||||||||
MIRT635691 | BMP10 | bone morphogenetic protein 10 | 2 | 2 | ||||||||
MIRT646438 | DNAH8 | dynein axonemal heavy chain 8 | 2 | 2 | ||||||||
MIRT651940 | UBN1 | ubinuclein 1 | 2 | 2 | ||||||||
MIRT663605 | TBC1D22A | TBC1 domain family member 22A | 2 | 2 | ||||||||
MIRT689759 | PRR13 | proline rich 13 | 2 | 2 | ||||||||
MIRT691916 | SRXN1 | sulfiredoxin 1 | 2 | 2 | ||||||||
MIRT698678 | TEF | TEF, PAR bZIP transcription factor | 2 | 2 | ||||||||
MIRT700924 | PDS5A | PDS5 cohesin associated factor A | 2 | 2 | ||||||||
MIRT707970 | PDE12 | phosphodiesterase 12 | 2 | 2 | ||||||||
MIRT715290 | CSTF1 | cleavage stimulation factor subunit 1 | 2 | 2 | ||||||||
MIRT722414 | RARS2 | arginyl-tRNA synthetase 2, mitochondrial | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|